000142071 001__ 142071
000142071 005__ 20240229105142.0
000142071 0247_ $$2doi$$a10.1016/j.pnmrs.2018.06.001
000142071 0247_ $$2pmid$$apmid:30527132
000142071 0247_ $$2ISSN$$a0079-6565
000142071 0247_ $$2ISSN$$a1873-3301
000142071 0247_ $$2altmetric$$aaltmetric:43954679
000142071 037__ $$aDKFZ-2018-02301
000142071 041__ $$aeng
000142071 082__ $$a530
000142071 1001_ $$0P:(DE-He78)022611a2317e4de40fd912e0a72293a8$$aLadd, Mark$$b0$$eFirst author$$udkfz
000142071 245__ $$aPros and cons of ultra-high-field MRI/MRS for human application.
000142071 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2018
000142071 3367_ $$2DRIVER$$aarticle
000142071 3367_ $$2DataCite$$aOutput Types/Journal article
000142071 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1661513728_13424$$xReview Article
000142071 3367_ $$2BibTeX$$aARTICLE
000142071 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142071 3367_ $$00$$2EndNote$$aJournal Article
000142071 520__ $$aMagnetic resonance imaging and spectroscopic techniques are widely used in humans both for clinical diagnostic applications and in basic research areas such as cognitive neuroimaging. In recent years, new human MR systems have become available operating at static magnetic fields of 7 T or higher (≥300 MHz proton frequency). Imaging human-sized objects at such high frequencies presents several challenges including non-uniform radiofrequency fields, enhanced susceptibility artifacts, and higher radiofrequency energy deposition in the tissue. On the other side of the scale are gains in signal-to-noise or contrast-to-noise ratio that allow finer structures to be visualized and smaller physiological effects to be detected. This review presents an overview of some of the latest methodological developments in human ultra-high field MRI/MRS as well as associated clinical and scientific applications. Emphasis is given to techniques that particularly benefit from the changing physical characteristics at high magnetic fields, including susceptibility-weighted imaging and phase-contrast techniques, imaging with X-nuclei, MR spectroscopy, CEST imaging, as well as functional MRI. In addition, more general methodological developments such as parallel transmission and motion correction will be discussed that are required to leverage the full potential of higher magnetic fields, and an overview of relevant physiological considerations of human high magnetic field exposure is provided.
000142071 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000142071 588__ $$aDataset connected to CrossRef, PubMed,
000142071 7001_ $$0P:(DE-He78)29b2f01310f7022916255ddba2750f9b$$aBachert, Peter$$b1$$udkfz
000142071 7001_ $$aMeyerspeer, Martin$$b2
000142071 7001_ $$0P:(DE-HGF)0$$aMoser, Ewald$$b3
000142071 7001_ $$0P:(DE-He78)054fd7a5195b75b11fbdc5c360276011$$aNagel, Armin$$b4$$udkfz
000142071 7001_ $$aNorris, David G$$b5
000142071 7001_ $$0P:(DE-He78)19e2d877276b0e5eec11cdfc1789a55e$$aSchmitter, Sebastian$$b6$$udkfz
000142071 7001_ $$aSpeck, Oliver$$b7
000142071 7001_ $$0P:(DE-He78)4e04dcea1b6a4449a8fa005bcf36322b$$aStraub, Sina$$b8$$udkfz
000142071 7001_ $$aZaiss, Moritz$$b9
000142071 773__ $$0PERI:(DE-600)1500674-8$$a10.1016/j.pnmrs.2018.06.001$$gVol. 109, p. 1 - 50$$p1 - 50$$tProgress in nuclear magnetic resonance spectroscopy$$v109$$x0079-6565$$y2018
000142071 909CO $$ooai:inrepo02.dkfz.de:142071$$pVDB
000142071 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)022611a2317e4de40fd912e0a72293a8$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000142071 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)29b2f01310f7022916255ddba2750f9b$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000142071 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000142071 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)054fd7a5195b75b11fbdc5c360276011$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000142071 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19e2d877276b0e5eec11cdfc1789a55e$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000142071 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4e04dcea1b6a4449a8fa005bcf36322b$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000142071 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000142071 9141_ $$y2018
000142071 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000142071 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142071 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPROG NUCL MAG RES SP : 2017
000142071 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142071 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142071 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000142071 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142071 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142071 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences
000142071 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bPROG NUCL MAG RES SP : 2017
000142071 9201_ $$0I:(DE-He78)E020-20160331$$kE020$$lE020 Med. Physik in der Radiologie$$x0
000142071 980__ $$ajournal
000142071 980__ $$aVDB
000142071 980__ $$aI:(DE-He78)E020-20160331
000142071 980__ $$aUNRESTRICTED